Acumen Pharmaceuticals Ownership | Who Owns Acumen Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Acumen Pharmaceuticals Ownership Summary


Acumen Pharmaceuticals is owned by 72.58% institutional investors, 11.24% insiders, and 16.19% retail investors. Ra capital management is the largest institutional shareholder, holding 24.96% of ABOS shares. Franklin Biotechnology Discv A(acc)USD is the top mutual fund, with 2.46% of its assets in Acumen Pharmaceuticals shares.

ABOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAcumen Pharmaceuticals72.58%11.24%16.19%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ra capital management14.93M24.96%$36.14M
Sands capital ventures3.42M5.71%$8.27M
Franklin resources3.37M5.63%$8.15M
Rock springs capital management lp2.30M3.85%$5.57M
Blackrock2.16M3.61%$5.22M
Fmr2.02M3.38%$4.89M
Millennium management1.95M3.27%$4.73M
Vanguard group1.90M3.17%$4.59M
Knollwood investment advisory1.63M2.72%$3.94M
Laurion capital management lp1.18M1.97%$2.85M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Sands capital ventures3.42M2.77%$8.27M
Ra capital management14.93M0.48%$36.14M
Knollwood investment advisory1.63M0.44%$3.94M
Rock springs capital management lp2.30M0.17%$5.57M
Ikarian capital266.44K0.11%$644.77K
Catalyst financial partners89.70K0.05%$217.07K
Laurion capital management lp1.18M0.03%$2.85M
Intrepid financial planning group30.15K0.03%$72.96K
Alyeska investment group939.60K0.01%$2.27M
Bridgeway capital management148.40K0.01%$359.13K

Top Buyers

HolderShares% AssetsChange
Blackrock2.16M0.00%1.97M
Geode capital management812.13K0.00%526.99K
State street436.56K-354.79K
Renaissance338.10K0.00%338.10K
Vanguard group1.90M0.00%231.89K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp1.18M0.03%-716.68K
Millennium management1.95M0.00%-675.46K
Parkman healthcare partners---576.66K
Goldman sachs group51.05K--266.85K
Tang capital management---246.90K

New Positions

HolderShares% AssetsChangeValue
Renaissance338.10K0.00%338.10K$818.20K
Bank of new york mellon126.42K0.00%126.42K$305.94K
Charles schwab investment management108.74K0.00%108.74K$263.16K
Nuveen asset management56.66K-56.66K$137.13K
Rhumbline advisers52.32K0.00%52.32K$126.62K

Sold Out

HolderChange
Redwood wealth management group-800.00
Kelly financial services-944.00
Macquarie group-1.25K
Sandy spring bank-1.50K
Point72 (difc)-4.02K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202477-10.47%43,605,2660.06%721.37%34-24.44%2110.53%
Jun 30, 2024862.38%43,581,2970.50%721.30%45-8.16%19-13.64%
Mar 31, 20248416.67%43,366,07612.88%741.49%494.26%22144.44%
Dec 31, 202372-1.37%38,419,207-11.04%700.64%47-9-18.18%
Sep 30, 20237321.67%43,186,72663.99%1052.55%47104.35%11-45.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Franklin Biotechnology Discv A(acc)USD1.48M2.46%-
Franklin Small Cap Growth SMA1.19M1.98%1.19M
Franklin US Small Cap Growth Equity1.19M1.98%-12.21K
Franklin Small Cap Growth Adv1.19M1.98%-
Vanguard Total Stock Mkt Idx Inv1.15M1.91%-
Fidelity Select Health Care1.14M1.90%-
iShares Russell 2000 ETF1.01M1.68%-2.27K
Franklin Biotechnology Discovery A826.40K1.38%-
Fidelity Advisor Health Care I700.00K1.17%-
Vanguard Institutional Extnd Mkt Idx Tr472.17K0.79%-

Recent Insider Transactions


DateNameRoleActivityValue
Jan 19, 2024OConnell Daniel Joseph President and CEOSell$52.75K
Jan 19, 2024Meisner Derek M Chief Legal Officer & Corp SecSell$31.05K
Jan 18, 2024Zuga Matt CFO & Chief Business OfficerSell$15.72K
Jan 18, 2024Siemers Eric Chief Medical OfficerSell$11.60K
Jan 18, 2024Barton Russell Chief Operating OfficerSell$10.56K

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q2--
2024 Q1-5
2023 Q312
2023 Q2--

ABOS Ownership FAQ


Who Owns Acumen Pharmaceuticals?

Acumen Pharmaceuticals shareholders are primarily institutional investors at 72.58%, followed by 11.24% insiders and 16.18% retail investors. The average institutional ownership in Acumen Pharmaceuticals's industry, Biotech Stocks , is 47.04%, which Acumen Pharmaceuticals exceeds.

Who owns the most shares of Acumen Pharmaceuticals?

Acumen Pharmaceuticals’s largest shareholders are Ra capital management (14.93M shares, 24.96%), Sands capital ventures (3.42M shares, 5.71%), and Franklin resources (3.37M shares, 5.63%). Together, they hold 36.31% of Acumen Pharmaceuticals’s total shares outstanding.

Does Blackrock own Acumen Pharmaceuticals?

Yes, BlackRock owns 3.61% of Acumen Pharmaceuticals, totaling 2.16M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 5.22M$. In the last quarter, BlackRock increased its holdings by 1.97M shares, a 1037.95% change.

Who is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Sands capital ventures is Acumen Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.77% of its assets in 3.42M Acumen Pharmaceuticals shares, valued at 8.27M$.

Who is the top mutual fund holder of Acumen Pharmaceuticals shares?

Franklin Biotechnology Discv A(acc)USD is the top mutual fund holder of Acumen Pharmaceuticals shares, with 2.46% of its total shares outstanding invested in 1.48M Acumen Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools